India Stem Cell Banking Market Sales Revenue Opportunity Report

Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued at more than INR 400 Crore (US$ 70 Million) in 2013. The current stem cell preservation level for new born baby is below 1% and hence there exists immense opportunity for stem cell preservation service providers to grow exponentially in coming years. With more than 20 million births every year there exist ample market opportunity for large number of stem cells banks to enter Indian stem cell preservation market and expand their services portfolio. The market potential of stem cell banking in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new born babies.

Download Report:

https://www.kuickresearch.com/report-India-Stem-Cell-Banking-Market-Analysis.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"India Stem Cell Banking Market Analysis" Table of Contents

1. India Stem Cell Research & Therapy Market Overview

2. India Stem Cell Banking Market Overview
2.1 Current Market Scenario
2.2 Cord Blood Banking
2.3 Menstrual Blood Banking
2.4 Cost Analysis
2.5 Issues to be Resolved
2.6 Future Growth Avenues

3. Preferred Business Model for Stem Cell Banks
3.1 Public Private Partnership
3.2 In-House Stem Cell Banks by Hospitals
3.3 Tie Up with Hospital Chains
3.4 Stand Alone Stem Cell Banks

4. Regulatory & Policy Framework
4.1 Past (2007) - Guidelines for Stem Cell Research and Therapy
4.2 Present (2012) - Guidelines for Stem Cell Research
4.3 2012 Guidelines: At a Glance

5. Institutional Support Framework
5.1 Centre for Stem Cell Research
5.2 Indian Council of Medical Research
5.3 Department of Biotechnology

6. Competitive Landscape
6.1 LifeCell
6.2 Cryobank India
6.3 CordLife
6.4 Unistem
6.5 ReliCord

Figure 2-1: Stem Cell Banking Market (INR Crore & US$ Million), 2012-2020
Figure 2-2: Stem Cell Banking Market Opportunity by Region
Figure 2-3: Stem Cell Preservation Penetration in India, US & Europe
Figure 2-4: Top 5 Factors Impacting Growth of Stem Cell Business in India
Figure 2-5: Number of Preserved Stem Cells (‘000) at Multiple Preservation Penetration Level (1% to 5%)
Figure 2-6: Stem Cell Banking Market Opportunity (US$ Million) at Multiple Preservation Penetration Level (1% to 5%)
Figure 2-7: Suggested Measures for Increasing Market for Cord Blood Banking in India
Figure 2-8: Measures to Make Cord Blood Banking Success in India
Figure 2-9: Number of Umbilical Cords Storage (’000), 2012-2020

List of Tables

Table 1-1: Institutes, Hospitals and Industries Involved in Stem Cell Research
Table 1-2: Private & Public Institutions Offering Stem Cell Banking in India
Table 2-1: Unique Issues Related to Cord Blood Transplantation
Table 2-2: Public v/s Private Stem Cell Banks
Table 2-3: Comparative Procedure Charges in India & US (US$)
Table 2-4: Stem Cell Banking Plans & Costs for Lifecell
Table 2-5: Stem Cell Banking Plans & Costs for Cryobanks
Table 2-6: Global Stem Cell Banking Pricing Matrix (US$)

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.